Brian Della Fera
YOU?
Author Swipe
View article: 510 A PD-L1 reporter cell line based on the immune checkpoint protein profiling of ATCC cell lines facilitates cancer immunotherapy drug screening
510 A PD-L1 reporter cell line based on the immune checkpoint protein profiling of ATCC cell lines facilitates cancer immunotherapy drug screening Open
Background The success of immune checkpoint inhibitors in the treatment of various types of cancers and their continued growth in the market have driven burgeoning interests in developing more drugs in this category. However, the intrinsic…
View article: 220 Luciferase reporter cancer cell lines facilitate CAR-T development
220 Luciferase reporter cancer cell lines facilitate CAR-T development Open
Background Chimeric antigen receptor (CAR)-T cells have displayed remarkable efficacy in treating malignant cancers, particularly liquid tumors. CAR-T cells have proven to be a new type of "living" therapeutic by harnessing the patient's i…